Enter any phrase or word you would like to search for and click .
PostNews: Press Release
Big Pharma embraces HoloMonitor technology from PHI
Upon completion of an extensive evaluation in early September one of the top pharmaceutical companies in the world has decided to acquire two HoloMonitor® instruments. The ordered configuration is an automated version of the HoloMonitor platform.
Learn more …
PostNews: Press Release
HoloMonitor technology help researchers fight ovarian cance
Ovarian cancer is one of the deadliest forms of cancer. Researchers at the Center of Excellence for Holographic Imaging at Northeastern University in Boston have used HoloMonitor technology to study how the immune system can be stimulated to fight this deadly cancer form. The research results have been published in Journal of Clinical & Cellular Immunology.
Learn more …
PostPress Release
Phase Holographic Imaging receives first order from United Kingdom after exhibition
Learn more …
PostNews
Florida International University and PHI collaborate to fight cancer
Learn more …
PostNews: Press Release
PHI provides second HoloMonitor® to University of California, San Francisco to accelerate skin cancer research
PHI has entered into a collaboration agreement with University of California, San Francisco (UCSF) to accelerate ongoing skin cancer research at UCSF.
Learn more …
PostNews
HoloMonitor technology shows versatility as important tool in nanotechnology research
Learn more …